speb/financial-data huggingface dataset:
CLOV balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 30523000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Current Assets: 331409000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 215653000.00
CLOV cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 466000.00
CLOV income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 466000.00
CLOV cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 466000.00
CLOV income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 466000.00
CLOV income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 497056331.00
CLOV income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
CLOV income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1274000.00
CLOV income_statement (quarterly, 2025-03-31) — EBIT: -1274000.00
CLOV income_statement (quarterly, 2025-03-31) — EBITDA: -808000.00
CLOV cash_flow (quarterly, 2025-03-31) — End Cash Position: 155439000.00
CLOV cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -31741000.00
CLOV cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -16478000.00
CLOV cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -42000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -74000.00
CLOV income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 109697000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2990000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Gross PPE: 5026000.00
CLOV income_statement (quarterly, 2025-03-31) — Gross Profit: 108889000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 14247000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Invested Capital: 336075000.00
CLOV cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 8930000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 230753000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 230753000.00
CLOV cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 215000.00
CLOV cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -31741000.00
CLOV income_statement (quarterly, 2025-03-31) — Net Income: -1274000.00
CLOV income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1274000.00
CLOV income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1274000.00
CLOV income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
CLOV income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1274000.00
CLOV income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1274000.00
CLOV cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1274000.00
CLOV income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1274000.00
CLOV cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 9115000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Net PPE: 5026000.00
CLOV cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -185000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 333085000.00
CLOV income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -808000.00
CLOV income_statement (quarterly, 2025-03-31) — Normalized Income: -1274000.00
CLOV cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -16293000.00
CLOV cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -42000.00
CLOV income_statement (quarterly, 2025-03-31) — Operating Income: -1274000.00
CLOV income_statement (quarterly, 2025-03-31) — Operating Revenue: 456906000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 506536539.00
CLOV balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 16469000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 3539000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -74000.00
CLOV income_statement (quarterly, 2025-03-31) — Other Gand A: 50675000.00
CLOV cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 103000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 13539000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 31989000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Other Payable: 151038000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Other Properties: 5026000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Other Receivables: 138256000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 4656000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Payables: 181591000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 212114000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 16589000.00
CLOV income_statement (quarterly, 2025-03-31) — Pretax Income: -1274000.00
CLOV cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -33169000.00
CLOV cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -185000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Receivables: 138256000.00
CLOV income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 353442000.00
CLOV income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 466000.00
CLOV cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -31956000.00
CLOV income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
CLOV balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -2204077000.00
CLOV income_statement (quarterly, 2025-03-31) — Salaries And Wages: 59022000.00
CLOV cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 42284000.00
CLOV income_statement (quarterly, 2025-03-31) — Selling General And Administration: 109697000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Share Issued: 532192127.00
CLOV income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
CLOV cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 26437000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 336075000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 333085000.00
CLOV income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CLOV income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CLOV balance_sheet (quarterly, 2025-03-31) — Total Assets: 583717000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 336075000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 336075000.00
CLOV income_statement (quarterly, 2025-03-31) — Total Expenses: 463605000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 247642000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 252308000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 31989000.00
CLOV income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1274000.00
CLOV income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
CLOV income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CLOV balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 25655588.00
CLOV balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 62947000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Working Capital: 115756000.00
CLOV income_statement (quarterly, 2025-06-30) — +Operating Expense: 110187000.00
CLOV income_statement (quarterly, 2025-06-30) — +Total Revenue: 477620000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 33951000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 2630021000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 175470000.00
CLOV income_statement (quarterly, 2025-06-30) — Basic Average Shares: 509043210.00
CLOV income_statement (quarterly, 2025-06-30) — Basic EPS: -0.02
CLOV cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 155439000.00
CLOV cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -569000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Capital Stock: 51000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 188648000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 201272000.00
CLOV cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -7765000.00
CLOV cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 35566000.00
CLOV cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 5408000.00
CLOV cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Operating Activities: 0.00
CLOV cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 3398000.00
CLOV cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -5339000.00
CLOV cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -937000.00
CLOV cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -3515000.00
CLOV cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -11378000.00
CLOV cash_flow (quarterly, 2025-06-30) — Change In Payable: 3398000.00
CLOV cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -1941000.00
CLOV cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1337000.00
CLOV cash_flow (quarterly, 2025-06-30) — Change In Receivables: 6909000.00
CLOV cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -9525000.00
CLOV cash_flow (quarterly, 2025-06-30) — Changes In Cash: 33209000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Common Stock: 51000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 344179000.00
CLOV cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 703000.00
CLOV cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -8468000.00
CLOV income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 377992000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 25184000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Current Assets: 362939000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 201948000.00
CLOV cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 394000.00
CLOV income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 394000.00
CLOV cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 394000.00
CLOV income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 394000.00
CLOV income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 509043210.00
CLOV income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.02
CLOV income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -10578000.00
CLOV income_statement (quarterly, 2025-06-30) — EBIT: -10559000.00
CLOV income_statement (quarterly, 2025-06-30) — EBITDA: -10165000.00
CLOV cash_flow (quarterly, 2025-06-30) — End Cash Position: 188648000.00
CLOV cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -7765000.00
CLOV cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 4839000.00
CLOV cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -376000.00
CLOV income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -19000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 177000.00
CLOV income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 109793000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2990000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Gross PPE: 5201000.00
CLOV income_statement (quarterly, 2025-06-30) — Gross Profit: 99628000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 12526000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Invested Capital: 344179000.00
CLOV cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 35566000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 187996000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 187996000.00
CLOV cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 703000.00
CLOV cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -7765000.00
CLOV income_statement (quarterly, 2025-06-30) — Net Income: -10578000.00
CLOV income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -10578000.00
CLOV income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -10578000.00
CLOV income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
CLOV income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -10578000.00
CLOV income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -10578000.00
CLOV cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -10578000.00
CLOV income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -10578000.00
CLOV cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 36135000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Net PPE: 5201000.00
CLOV cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -569000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 341189000.00
CLOV income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -10146000.00
CLOV income_statement (quarterly, 2025-06-30) — Normalized Income: -10559000.00
CLOV cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 5408000.00
CLOV cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -376000.00
CLOV income_statement (quarterly, 2025-06-30) — Operating Income: -10559000.00
CLOV income_statement (quarterly, 2025-06-30) — Operating Revenue: 469826000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 510761778.00
CLOV balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 15068000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 3153000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 177000.00
CLOV income_statement (quarterly, 2025-06-30) — Other Gand A: 48484000.00
CLOV income_statement (quarterly, 2025-06-30) — Other Income Expense: -19000.00
CLOV cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -702000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 15861000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 28860000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Other Payable: 139660000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Other Properties: 5201000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Other Receivables: 131347000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 12624000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Payables: 173611000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 198795000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 15252000.00
CLOV income_statement (quarterly, 2025-06-30) — Pretax Income: -10578000.00
CLOV cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -26695000.00
CLOV cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -569000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Receivables: 131347000.00
CLOV income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 377992000.00
CLOV income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 394000.00
CLOV cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -8468000.00
CLOV income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 0.00
CLOV balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -2214655000.00
CLOV income_statement (quarterly, 2025-06-30) — Salaries And Wages: 61309000.00
CLOV cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 62830000.00
CLOV income_statement (quarterly, 2025-06-30) — Selling General And Administration: 109793000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Share Issued: 538894161.00
CLOV income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CLOV cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 26195000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 344179000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 341189000.00
CLOV income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CLOV income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CLOV balance_sheet (quarterly, 2025-06-30) — Total Assets: 574987000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 344179000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 344179000.00
CLOV income_statement (quarterly, 2025-06-30) — Total Expenses: 488179000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 230808000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 212048000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 28860000.00
CLOV income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -10559000.00
CLOV income_statement (quarterly, 2025-06-30) — Total Unusual Items: -19000.00
CLOV income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -19000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 28132383.00
CLOV balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 71415000.00
CLOV balance_sheet (quarterly, 2025-06-30) — Working Capital: 160991000.00
CLOV income_statement (quarterly, 2025-09-30) — +Operating Expense: 97554000.00
CLOV income_statement (quarterly, 2025-09-30) — +Total Revenue: 496650000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 32938000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 2656432000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 180682000.00
CLOV income_statement (quarterly, 2025-09-30) — Basic Average Shares: 512743521.00
CLOV income_statement (quarterly, 2025-09-30) — Basic EPS: -0.05
CLOV cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 188648000.00
CLOV cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -692000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Capital Stock: 51000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 190055000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 202840000.00
CLOV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -5271000.00
CLOV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -5425000.00
CLOV cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 12103000.00
CLOV cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Operating Activities: 0.00
CLOV cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -1013000.00
CLOV cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -8013000.00
CLOV cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -8367000.00
CLOV cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -3852000.00
CLOV cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 797000.00
CLOV cash_flow (quarterly, 2025-09-30) — Change In Payable: -1013000.00
CLOV cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -9026000.00
CLOV cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 2785000.00
CLOV cash_flow (quarterly, 2025-09-30) — Change In Receivables: 27836000.00
CLOV cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 10173000.00
CLOV cash_flow (quarterly, 2025-09-30) — Changes In Cash: 1407000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Common Stock: 51000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 340932000.00
CLOV cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 305000.00
CLOV cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -5576000.00
CLOV income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 423473000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 17171000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Current Assets: 330920000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 193447000.00
CLOV cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 406000.00
CLOV income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 406000.00
CLOV cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 406000.00
CLOV income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 406000.00
CLOV income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 512743521.00
CLOV income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.05
CLOV income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -24377000.00
CLOV income_statement (quarterly, 2025-09-30) — EBIT: -24377000.00
CLOV income_statement (quarterly, 2025-09-30) — EBITDA: -23971000.00
CLOV cash_flow (quarterly, 2025-09-30) — End Cash Position: 190055000.00
CLOV cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -5271000.00
CLOV cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 11411000.00
CLOV cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -188000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 471000.00
CLOV income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 97148000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2990000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Gross PPE: 5487000.00
CLOV income_statement (quarterly, 2025-09-30) — Gross Profit: 73177000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 12384000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Invested Capital: 340932000.00
CLOV cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -5425000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 193066000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 193066000.00
CLOV cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 305000.00
CLOV cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -5271000.00
CLOV income_statement (quarterly, 2025-09-30) — Net Income: -24377000.00
CLOV income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -24377000.00
CLOV income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -24377000.00
CLOV income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
CLOV income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -24377000.00
CLOV income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -24377000.00
CLOV cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -24377000.00
CLOV income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -24377000.00
CLOV cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -4733000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Net PPE: 5487000.00
CLOV cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -692000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 337942000.00
CLOV income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -23971000.00
CLOV income_statement (quarterly, 2025-09-30) — Normalized Income: -24377000.00
CLOV cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 12103000.00
CLOV cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -188000.00
CLOV income_statement (quarterly, 2025-09-30) — Operating Income: -24377000.00
CLOV income_statement (quarterly, 2025-09-30) — Operating Revenue: 479128000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 514194229.00
CLOV balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 12102000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 2881000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 471000.00
CLOV income_statement (quarterly, 2025-09-30) — Other Gand A: 48953000.00
CLOV cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -17000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 27196000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 25280000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Other Payable: 140457000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Other Properties: 5487000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Other Receivables: 103511000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 12785000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Payables: 173395000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 190566000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 12467000.00
CLOV income_statement (quarterly, 2025-09-30) — Pretax Income: -24377000.00
CLOV cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -39127000.00
CLOV cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -692000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Receivables: 103511000.00
CLOV income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 423473000.00
CLOV income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 406000.00
CLOV cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -5576000.00
CLOV income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
CLOV balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -2239032000.00
CLOV income_statement (quarterly, 2025-09-30) — Salaries And Wages: 48195000.00
CLOV cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 34394000.00
CLOV income_statement (quarterly, 2025-09-30) — Selling General And Administration: 97148000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Share Issued: 544458768.00
CLOV income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CLOV cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 26106000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 340932000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 337942000.00
CLOV income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CLOV income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CLOV balance_sheet (quarterly, 2025-09-30) — Total Assets: 559659000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 340932000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 340932000.00
CLOV income_statement (quarterly, 2025-09-30) — Total Expenses: 521027000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 218727000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 228739000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 25280000.00
CLOV income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -24377000.00
CLOV income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
CLOV income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CLOV balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 30264539.00
CLOV balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 76990000.00
CLOV balance_sheet (quarterly, 2025-09-30) — Working Capital: 137473000.00
CLOV income_statement (annual, 2025-12-31) — +Operating Expense: 441431000.00
CLOV income_statement (quarterly, 2025-12-31) — +Operating Expense: 123527000.00
CLOV income_statement (annual, 2025-12-31) — +Total Revenue: 1924308000.00
CLOV income_statement (quarterly, 2025-12-31) — +Total Revenue: 487707000.00
CLOV balance_sheet (annual, 2025-12-31) — Accounts Payable: 36211000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 36211000.00
CLOV balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7600000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7600000.00
CLOV balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2682663000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2682663000.00
CLOV cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
CLOV balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 187092000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 187092000.00
CLOV income_statement (annual, 2025-12-31) — Basic Average Shares: 511967146.00
CLOV income_statement (quarterly, 2025-12-31) — Basic Average Shares: 517237340.00
CLOV income_statement (annual, 2025-12-31) — Basic EPS: -0.17
CLOV income_statement (quarterly, 2025-12-31) — Basic EPS: -0.10
CLOV cash_flow (annual, 2025-12-31) — Beginning Cash Position: 194543000.00
CLOV cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 190055000.00
CLOV cash_flow (annual, 2025-12-31) — Capital Expenditure: -2043000.00
CLOV cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -597000.00
CLOV balance_sheet (annual, 2025-12-31) — Capital Stock: 52000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Capital Stock: 52000.00
CLOV balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 78301000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 78301000.00
CLOV balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 120256000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 120256000.00
CLOV cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -53384000.00
CLOV cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -8607000.00
CLOV cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 4076000.00
CLOV cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -34995000.00
CLOV cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -66934000.00
CLOV cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -68152000.00
CLOV cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: 0.00
CLOV cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Operating Activities: 0.00
CLOV cash_flow (annual, 2025-12-31) — Change In Account Payable: 1647000.00
CLOV cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 3273000.00
CLOV cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -3052000.00
CLOV cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -1133000.00
CLOV cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -5921000.00
CLOV cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 4530000.00
CLOV cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -2741000.00
CLOV cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1353000.00
CLOV cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -3146000.00
CLOV cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 12793000.00
CLOV cash_flow (annual, 2025-12-31) — Change In Payable: 1647000.00
CLOV cash_flow (quarterly, 2025-12-31) — Change In Payable: 3273000.00
CLOV cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -1405000.00
CLOV cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2140000.00
CLOV cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -5035000.00
CLOV cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -5742000.00
CLOV cash_flow (annual, 2025-12-31) — Change In Receivables: -65949000.00
CLOV cash_flow (quarterly, 2025-12-31) — Change In Receivables: -55230000.00
CLOV cash_flow (annual, 2025-12-31) — Change In Working Capital: -84197000.00
CLOV cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -42862000.00
CLOV cash_flow (annual, 2025-12-31) — Changes In Cash: -116242000.00
CLOV cash_flow (quarterly, 2025-12-31) — Changes In Cash: -111754000.00
CLOV balance_sheet (annual, 2025-12-31) — Common Stock: 52000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Common Stock: 52000.00
CLOV balance_sheet (annual, 2025-12-31) — Common Stock Equity: 308704000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 308704000.00
CLOV cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1814000.00
CLOV cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 591000.00
CLOV cash_flow (annual, 2025-12-31) — Common Stock Payments: -55198000.00
CLOV cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -9198000.00
CLOV income_statement (annual, 2025-12-31) — Cost Of Revenue: 1568406000.00
CLOV income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 413499000.00
CLOV balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 16038000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 16038000.00
CLOV balance_sheet (annual, 2025-12-31) — Current Assets: 307855000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Current Assets: 307855000.00
CLOV balance_sheet (annual, 2025-12-31) — Current Liabilities: 208823000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 208823000.00
CLOV cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1686000.00
CLOV cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 420000.00
CLOV income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1686000.00
CLOV income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 420000.00
CLOV cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1686000.00
CLOV cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 420000.00
CLOV income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 1686000.00
CLOV income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 420000.00
CLOV income_statement (annual, 2025-12-31) — Diluted Average Shares: 511967146.00
CLOV income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 517237340.00
CLOV income_statement (annual, 2025-12-31) — Diluted EPS: -0.17
CLOV income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.10
CLOV income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -85549000.00
CLOV income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -49320000.00
CLOV income_statement (annual, 2025-12-31) — EBIT: -85549000.00
CLOV income_statement (quarterly, 2025-12-31) — EBIT: -49339000.00
CLOV income_statement (annual, 2025-12-31) — EBITDA: -83863000.00
CLOV income_statement (quarterly, 2025-12-31) — EBITDA: -48919000.00
CLOV cash_flow (annual, 2025-12-31) — End Cash Position: 78301000.00
CLOV cash_flow (quarterly, 2025-12-31) — End Cash Position: 78301000.00
CLOV cash_flow (annual, 2025-12-31) — Financing Cash Flow: -53384000.00
CLOV cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -8607000.00
CLOV cash_flow (annual, 2025-12-31) — Free Cash Flow: -68977000.00
CLOV cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -68749000.00
CLOV cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -959000.00
CLOV cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -353000.00
CLOV income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -20000.00
CLOV income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -1000.00
CLOV balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 528000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 528000.00
CLOV income_statement (annual, 2025-12-31) — General And Administrative Expense: 439745000.00
CLOV income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 123107000.00
CLOV balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2990000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2990000.00
CLOV balance_sheet (annual, 2025-12-31) — Gross PPE: 13985000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Gross PPE: 13985000.00
CLOV income_statement (annual, 2025-12-31) — Gross Profit: 355902000.00
CLOV income_statement (quarterly, 2025-12-31) — Gross Profit: 74208000.00
CLOV balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 12571000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 12571000.00
CLOV income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
CLOV income_statement (annual, 2025-12-31) — Interest Expense: 0.00
CLOV income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 0.00
CLOV balance_sheet (annual, 2025-12-31) — Invested Capital: 308704000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Invested Capital: 308704000.00
CLOV cash_flow (annual, 2025-12-31) — Investing Cash Flow: 4076000.00
CLOV cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -34995000.00
CLOV balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 199663000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 199663000.00
CLOV balance_sheet (annual, 2025-12-31) — Investments And Advances: 199663000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 199663000.00
CLOV cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 1814000.00
CLOV cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 591000.00
CLOV balance_sheet (annual, 2025-12-31) — Leases: 3035000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Leases: 3035000.00
CLOV balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 10837000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 10837000.00
CLOV cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -53384000.00
CLOV cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -8607000.00
CLOV income_statement (annual, 2025-12-31) — Net Income: -85549000.00
CLOV income_statement (quarterly, 2025-12-31) — Net Income: -49320000.00
CLOV income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -85549000.00
CLOV income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -49320000.00
CLOV income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -85549000.00
CLOV income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -49320000.00
CLOV income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
CLOV income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
CLOV income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -85549000.00
CLOV income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -49320000.00
CLOV income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -85549000.00
CLOV income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -49320000.00
CLOV cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -85549000.00
CLOV cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -49320000.00
CLOV income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -85549000.00
CLOV income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -49320000.00
CLOV income_statement (annual, 2025-12-31) — Net Interest Income: 0.00
CLOV cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 6119000.00
CLOV cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -34398000.00
CLOV income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 0.00
CLOV balance_sheet (annual, 2025-12-31) — Net PPE: 6385000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Net PPE: 6385000.00
CLOV cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2043000.00
CLOV cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -597000.00
CLOV balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 305714000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 305714000.00
CLOV income_statement (annual, 2025-12-31) — Normalized EBITDA: -83843000.00
CLOV income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -48918000.00
CLOV income_statement (annual, 2025-12-31) — Normalized Income: -85529000.00
CLOV income_statement (quarterly, 2025-12-31) — Normalized Income: -49319000.00
CLOV cash_flow (annual, 2025-12-31) — Operating Cash Flow: -66934000.00
CLOV cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -68152000.00
CLOV cash_flow (annual, 2025-12-31) — Operating Gains Losses: -959000.00
CLOV cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -353000.00
CLOV income_statement (annual, 2025-12-31) — Operating Income: -85529000.00
CLOV income_statement (quarterly, 2025-12-31) — Operating Income: -49319000.00
CLOV income_statement (annual, 2025-12-31) — Operating Revenue: 1891732000.00
CLOV income_statement (quarterly, 2025-12-31) — Operating Revenue: 485872000.00
CLOV balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 519042526.00
CLOV balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 519042526.00
CLOV balance_sheet (annual, 2025-12-31) — Other Current Assets: 10649000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 10649000.00
CLOV balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 3324000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 3324000.00
CLOV balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 528000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 528000.00
CLOV income_statement (annual, 2025-12-31) — Other Gand A: 214270000.00
CLOV income_statement (quarterly, 2025-12-31) — Other Gand A: 66158000.00
CLOV income_statement (annual, 2025-12-31) — Other Income Expense: -20000.00
CLOV income_statement (quarterly, 2025-12-31) — Other Income Expense: -1000.00
CLOV balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 2990000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 2990000.00
CLOV cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1572000.00
CLOV cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -956000.00
CLOV balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 24118000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 24118000.00
CLOV balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 23484000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 23484000.00
CLOV balance_sheet (annual, 2025-12-31) — Other Payable: 153250000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Other Payable: 153250000.00
CLOV balance_sheet (annual, 2025-12-31) — Other Properties: 113000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Other Properties: 113000.00
CLOV balance_sheet (annual, 2025-12-31) — Other Receivables: 158741000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Other Receivables: 158741000.00
CLOV balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 41955000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 41955000.00
CLOV balance_sheet (annual, 2025-12-31) — Payables: 189461000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Payables: 189461000.00
CLOV balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 205499000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 205499000.00
CLOV balance_sheet (annual, 2025-12-31) — Prepaid Assets: 18209000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 18209000.00
CLOV income_statement (annual, 2025-12-31) — Pretax Income: -85549000.00
CLOV income_statement (quarterly, 2025-12-31) — Pretax Income: -49320000.00
CLOV balance_sheet (annual, 2025-12-31) — Properties: 0.00
CLOV balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CLOV cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 0.00
CLOV cash_flow (annual, 2025-12-31) — Purchase Of Investment: -205097000.00
CLOV cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -106106000.00
CLOV cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2043000.00
CLOV cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -597000.00
CLOV balance_sheet (annual, 2025-12-31) — Receivables: 158741000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Receivables: 158741000.00
CLOV income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1568406000.00
CLOV income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 413499000.00
CLOV income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1686000.00
CLOV income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 420000.00
CLOV cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -55198000.00
CLOV cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -9198000.00
CLOV income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CLOV income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CLOV balance_sheet (annual, 2025-12-31) — Retained Earnings: -2288352000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -2288352000.00
CLOV income_statement (annual, 2025-12-31) — Salaries And Wages: 225475000.00
CLOV income_statement (quarterly, 2025-12-31) — Salaries And Wages: 56949000.00
CLOV cash_flow (annual, 2025-12-31) — Sale Of Investment: 211216000.00
CLOV cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 71708000.00
CLOV income_statement (annual, 2025-12-31) — Selling General And Administration: 439745000.00
CLOV income_statement (quarterly, 2025-12-31) — Selling General And Administration: 123107000.00
CLOV balance_sheet (annual, 2025-12-31) — Share Issued: 552454799.00
CLOV balance_sheet (quarterly, 2025-12-31) — Share Issued: 552454799.00
CLOV income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
CLOV income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CLOV cash_flow (annual, 2025-12-31) — Stock Based Compensation: 103657000.00
CLOV cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 24919000.00
CLOV balance_sheet (annual, 2025-12-31) — Stockholders Equity: 308704000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 308704000.00
CLOV balance_sheet (annual, 2025-12-31) — Tangible Book Value: 305714000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 305714000.00
CLOV income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLOV income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CLOV income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CLOV income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CLOV balance_sheet (annual, 2025-12-31) — Total Assets: 541011000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Total Assets: 541011000.00
CLOV balance_sheet (annual, 2025-12-31) — Total Capitalization: 308704000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 308704000.00
CLOV balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 308704000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 308704000.00
CLOV income_statement (annual, 2025-12-31) — Total Expenses: 2009837000.00
CLOV income_statement (quarterly, 2025-12-31) — Total Expenses: 537026000.00
CLOV balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 232307000.00
CLOV balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 232307000.00